Basics DexCom, Inc. DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. IPO Date: April 14, 2005 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $22.64B Activated in VL: True Average Daily Range Avg Daily Range: $1.72 | 2.04% Avg Daily Range (30 D): $1.06 | 1.68% Avg Daily Range (90 D): $1.19 | 1.64% Institutional Daily Volume Avg Daily Volume: 1.04M Avg Daily Volume (30 D): 5.94M Avg Daily Volume (90 D): 4.57M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 64 Institutional Trades Total Inst.Trades: 19,323 Avg Inst. Trade: $7.18M Avg Inst. Trade (30 D): $5.38M Avg Inst. Trade (90 D): $6.43M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 5 Market Closing Trades Avg Closing Trade: $23.64M Avg Closing Trade (30 D): $46.11M Avg Closing Trade (90 D): $46.28M Avg Closing Volume: 347.02K     News Nov 17, 2025 @ 8:51 PM Shareholders that lost money on DexCom, Inc. (DXCM... Source: Levi & Korsinsky, Llp Nov 16, 2025 @ 11:54 PM ROSEN, A LEADING NATIONAL FIRM, Encourages DexCom,... Source: Rosen Law Firm Nov 15, 2025 @ 4:13 PM Kessler Topaz Meltzer & Check, LLP Reminds DXCM In... Source: Kessler Topaz Meltzer & Check, Llp Nov 12, 2025 @ 12:15 PM DexCom Stock Just Fell to a 5-Year Low. Is It a No... Source: David Jagielski Nov 11, 2025 @ 5:41 PM Wall Street Pauses, Silver Reclaims $50 With Shutd... Source: Piero Cingari Financials   TTM Q3 2025 Q2 2025 Basic EPS $1.83 $.73 $.46 Diluted EPS $1.8 $.7 $.45 Revenue $ 4.52B $ 1.21B $ 1.16B Gross Profit $ 2.67B $ 731.4M $ 688.8M Net Income / Loss $ 720.7M $ 283.8M $ 179.8M Operating Income / Loss $ 777.7M $ 242.5M $ 212.6M Cost of Revenue $ 1.85B $ 477.9M $ 468.3M Net Cash Flow $ 1.21B $ 676.6M $ 254.2M PE Ratio 32.50     Splits Jun 13, 2022:   4:1